Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Scientific Reports|August 6, 2025
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancerLorenzo Castagnoli, Francesco Bonì, Martina Bigliardi, et al.Bioorganic & Medicinal Chemistry|October 16, 2012
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterizationDaniele Lecis, Eloise Mastrangelo, Laura Belvisi, et al.Archiv Der Pharmazie|December 19, 2023
A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitorsGreta Donati, Monica Viviano, Vincenzo Maria D'Amore, et al.Journal of Medicinal Chemistry|October 20, 2021
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 InhibitorsPasquale Russomanno, Giulia Assoni, Jussara Amato, et al.Journal of Medicinal Chemistry|February 23, 2026
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC ImmunotherapyFrancesco Merlino, Valentina Pagliara, Vincenzo Maria D'Amore, et al.Bioorganic & Medicinal Chemistry|July 22, 2009
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapyPierfausto Seneci, Aldo Bianchi, Cristina Battaglia, et al.Nucleic Acids Research|September 22, 2017
Regulation of HuR structure and function by dihydrotanshinone-IPreet Lal, Linda Cerofolini, Vito Giuseppe D'Agostino, et al.The Journal of Clinical Investigation|April 22, 2020
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasisMarta Palomo-Irigoyen, Encarni Pérez-Andrés, Marta Iruarrizaga-Lejarreta, et al.Pageof 7